Shopping Cart
- Remove All
- Your shopping cart is currently empty
CD24 is a sialoglycoprotein expressed at the surface of most B lymphocytes and differentiating neuroblasts. It is also expressed on neutrophils and neutrophil precursors from the myelocyte stage onwards. The potential for targeting CD24 in cancer therapy seems promising, as CD24 is overexpressed in many human cancers. CD24 Protein-VLP, Human, Recombinant is expressed in HEK293 mammalian cells. The predicted molecular weight is 5.0 kDa and the accession number is P25063-1.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
100 μg | $1,850 | 7-10 days | |
500 μg | $7,460 | 7-10 days | |
1 mg | $12,430 | 7-10 days |
Biological Activity | Immobilized Human CD24 VLP at 0.5μg/ml (100μl/Well) on the plate. Dose response curve for Anti-CD24 Antibody, hFc Tag with the EC50 of 16.4ng/ml determined by ELISA. |
Description | CD24 is a sialoglycoprotein expressed at the surface of most B lymphocytes and differentiating neuroblasts. It is also expressed on neutrophils and neutrophil precursors from the myelocyte stage onwards. The potential for targeting CD24 in cancer therapy seems promising, as CD24 is overexpressed in many human cancers. CD24 Protein-VLP, Human, Recombinant is expressed in HEK293 mammalian cells. The predicted molecular weight is 5.0 kDa and the accession number is P25063-1. |
Species | Human |
Expression System | HEK293 Cells |
Tag | Tag Free |
Accession Number | P25063-1 |
Synonyms | MGC75043,FLJ43543,FLJ22950,CD24A,CD24 molecule,CD 24 |
Construction | Ser27-Gly59 |
Molecular Weight | 5.0 kDa (predicted) |
Endotoxin | < 1 EU/μg by the LAL method. |
Formulation | Supplied as 0.22 μm filtered solution in PBS (pH 7.4).Notice: If you need it for immunization, Do Not use any adjuvant. |
Stability & Storage | It is recommended to store the product under sterile conditions at -70°C or lower. Samples are stable for up to 12 months at -80°C. Please avoid multiple freeze-thaw cycles and store products in aliquots. |
Shipping | Shipping with blue ice. |
Research Background | CD24 is a sialoglycoprotein expressed at the surface of most B lymphocytes and differentiating neuroblasts. It is also expressed on neutrophils and neutrophil precursors from the myelocyte stage onwards. The potential for targeting CD24 in cancer therapy seems promising, as CD24 is overexpressed in many human cancers. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.